SMARCA4 and neoplasm of thorax: In 2021, a new WHO classification of thoracic tumors of pulmonary epithelial origin is defined as SMARCA4-deficient undifferentiated tumor (SMARCA4-UT), which has distinct histopathological features and loss-of-function genomic alterations of the SMARCA4 gene [18].